The results of the ATTAIN-MAINTAIN trial, published May 12 in Nature Medicine, showed that switching to the once-daily orforglipron pill may address this need and help maintain the cardiometabolic benefits
Sahnis strategy involves: Comprehensive Assessment: Evaluating your blood sugar, heart health, and hormonal profile before starting treatment
People with gut issues or genetic predispositions can have a harder time with severe nausea
Inositol-1, 4, 5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes
While some individuals may be able to switch to a lower maintenance dose after achieving their weight loss goals, completely stopping treatment typically leads to a reversal of the progress made
Beyond Ozempic injections, we are here to help you figure out a sustainable routine that will give you the best results for your plan of care